Net profit of Bal Pharma declined 31.73% to Rs 0.71 crore in the quarter ended September 2025 as against Rs 1.04 crore during the previous quarter ended September 2024. Sales rose 0.45% to Rs 74.02 crore in the quarter ended September 2025 as against Rs 73.69 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales74.0273.69 0 OPM %7.7410.44 - PBDT2.993.84 -22 PBT0.721.36 -47 NP0.711.04 -32 Powered by Capital Market - Live News

Bal Pharma will hold a meeting of the Board of Directors of the Company on 12 November 2025.Powered by Capital Market - Live News

Bal Pharma announced that the 38th Annual General Meeting(AGM) of the company will be held on 25 September 2025.Powered by Capital Market - Live News

Net profit of Bal Pharma declined 19.23% to Rs 0.21 crore in the quarter ended June 2025 as against Rs 0.26 crore during the previous quarter ended June 2024. Sales declined 11.42% to Rs 65.87 crore in the quarter ended June 2025 as against Rs 74.36 crore during the previous quarter ended June 2024. ParticularsQuarter EndedJun. 2025Jun. 2024% Var. Sales65.8774.36 -11 OPM %9.208.69 - PBDT2.733.05 -10 PBT0.210.62 -66 NP0.210.26 -19 Powered by Capital Market - Live News

Bal Pharma will hold a meeting of the Board of Directors of the Company on 11 August 2025.Powered by Capital Market - Live News